Sign in
4

Changes in Ownership

LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-22-007175

VP, Chief Commercial Officer gave up 8,261 shares (to pay taxes)

  • VP, Chief Commercial Officer acquired 30,128 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Seth Kiernan · VP, Chief Commercial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-28 Exercise or conversion : show line 1 in the form +10,007 10,007 D
2022-02-28 Exercise or conversion : show line 2 in the form +14,834 24,841 D
2022-02-28 Exercise or conversion : show line 3 in the form +5,287 30,128 D
2022-02-28 Shares withheld for taxes : show line 4 in the form −8,261 $2.85 $23,544 21,867 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-02-28 Exercise or conversion : show line 5 in the form Restricted Stock Units −10,007 0 D
2022-02-28 Exercise or conversion : show line 6 in the form Restricted Stock Units −14,834 14,833 D
2022-02-28 Exercise or conversion : show line 7 in the form Restricted Stock Units −5,287 10,573 D
Loading xslF345X03/form4.xml…